Neuritin1 Cis -Regulatory Elements Enable Gene Expression Preferentially in Retinal Ganglion Cells
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.4.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Venu Talla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, United States. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Gene Expression Regulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Purpose
Retinal ganglion cells (RGCs) are essential for visual signal transmission, yet they are vulnerable to injury and degeneration. Gene modulation in RGCs using adeno-associated virus (AAV) offers a promising avenue for neuroprotection and regeneration, but promoters lack sufficient RGC specificity, limiting the precision needed for preclinical studies. This study aims to identify novel promoter-enhancer combinations (PECs) to achieve gene expression preferentially in RGCs.
Methods
We evaluated existing transcriptomic data to identify neuritin 1 (Nrn1) as a gene with highly restricted RGC expression in the retina. Synthetic PECs derived from human and mouse Nrn1 loci were incorporated into AAV2 vectors driving expression of a nuclear-targeted reporter GreenLantern. AAVs were delivered via intravitreal injection into C57BL6/J mice, and transduction efficiency and RGC specificity were evaluated in both young and aged retinas and those subjected to intraorbital optic nerve crush (ONC), using immunohistochemistry and quantitative analysis of RBPMS+ cells.
Results
We found that AAV2 with a human Nrn1-PEC drives gene expression in RGCs. Quantitative analysis revealed that over 83% of transduced cells were RBPMS+, indicating robust RGC selectivity and significantly outperforming ubiquitous promoters. Notably, the Nrn1-PEC retained strong and selective transgene expression in RGCs in aged mice and following ONC, demonstrating its resilience under aged and injury conditions.
Conclusions
The Nrn1-PEC enables efficient and injury-resilient gene expression in RGCs, addressing a key limitation in cell-specific targeting. This AAV-incorporated PEC offers a robust platform for evaluating neuroprotective interventions and accelerates the translational development of gene therapies for glaucoma and other optic neuropathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
- Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
- Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Förderung
- NEI NIH HHS
Zitieren
APA
Talla, V., Koilkonda, R., Kinane, C., Panchal, M., Khuu, T., & Park, K. K. (2026). Neuritin1 Cis -Regulatory Elements Enable Gene Expression Preferentially in Retinal Ganglion Cells. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.4.18
Vancouver
Talla V, Koilkonda R, Kinane C, Panchal M, Khuu T, Park KK. Neuritin1 Cis -Regulatory Elements Enable Gene Expression Preferentially in Retinal Ganglion Cells. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.4.18
BibTeX
@article{Talla2026,
author = {Talla, Venu and Koilkonda, Rajeshwari and Kinane, Chaimaa and Panchal, Moxa and Khuu, Tamdan and Park, Kevin K},
title = {Neuritin1 Cis -Regulatory Elements Enable Gene Expression Preferentially in Retinal Ganglion Cells},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.4.18}
}
EUVIMED